SCHEMBL13638236

SCHEMBL13638236

BNc1cc(Cl)nc(SC)n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.55
MEN1 O00255 5/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
GAA P10253 1/20 0.55
POLB P06746 1/20 0.42
HTT P42858 1/20 0.40
AURKA O14965 2/20 0.38
AURKB Q96GD4 2/20 0.38
PPARA Q07869 9/20 0.34
PPARG P37231 8/20 0.33
RXRA P19793 7/20 0.33
RXRB P28702 6/20 0.33
RXRG P48443 5/20 0.33
PPARD Q03181 3/20 0.33
KDM4E B2RXH2 1/20 0.32
ABCC4 O15439 1/20 0.32
ABCB11 O95342 1/20 0.32
ALDH1A1 P00352 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2614898 0.82 KMT2A (0.57) KMT2AMEN1SMN1; SMN2GAAPOLB
SCHEMBL3038360 0.81 KMT2A (0.56) KMT2AMEN1SMN1; SMN2GAAPOLB
SCHEMBL31073526 0.81 KMT2A (0.56) KMT2AMEN1SMN1; SMN2GAAPOLB
SCHEMBL31073527 0.81 KMT2A (0.56) KMT2AMEN1SMN1; SMN2GAAPOLB
SCHEMBL19686555 0.79 KMT2A (0.54) KMT2AMEN1SMN1; SMN2GAAPOLB
SCHEMBL62021 0.79 POLB (0.53) KMT2AMEN1SMN1; SMN2GAAPOLB
SCHEMBL11378579 0.78 KMT2A (0.53) KMT2AMEN1SMN1; SMN2GAAPOLB
SCHEMBL11371064 0.78 KMT2A (0.53) KMT2AMEN1SMN1; SMN2GAAPOLB
SCHEMBL3079698 0.78 KMT2A (0.56) KMT2AMEN1SMN1; SMN2GAAPOLB
SCHEMBL23846000 0.75 KMT2A (0.50) KMT2AMEN1SMN1; SMN2GAAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090275577-A1 IMIDAZOPYRIDINE AND IMIDAZOPYRIMIDINE DERIVATIVES AS ANTIBACTERIAL AGENTS PFIZER INC 2009-11-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275577-A1 IMIDAZOPYRIDINE AND IMIDAZOPYRIMIDINE DERIVATIVES AS ANTIBACTERIAL AGENTS DPYD, TYMP, ITPA KMT2A 4669/4885MEN1 3353/4885SMN1; SMN2 1846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.